Former Maker of Lucira-Brand Covid-19 Tests to Liquidate

The former maker of Lucira-brand Covid-19 home tests won bankruptcy court approval of a debt repayment plan and will liquidate after it sold its business to Pfizer Inc. earlier this year.

• Judge Mary Walrath said during a court hearing Tuesday in Delaware that she’d approve the liquidation plan of Lucira Health Inc., which filed Chapter 11 in February
  • Lucira grew at the start of the pandemic, pitching its at-home tests as providing “lab-quality results” in 30 minutes, but struggled with falling demand as Covid-19 restrictions eased
• Lucira Health sold its business in Chapter 11 to Pfizer for $36.4 million ...